Noninvasive Magnetic Resonance Imaging Evaluation of Endothelial Permeability in Murine Atherosclerosis Using an Albumin-Binding Contrast Agent
Author(s) -
Alkystis Phinikaridou,
Marcelo E. Andía,
Andrea Protti,
Andreas Indermuehle,
Ajay M. Shah,
Alberto Smith,
Alice Warley,
René M. Botnar
Publication year - 2012
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.112.092098
Subject(s) - medicine , apolipoprotein e , endothelial dysfunction , endothelial stem cell , magnetic resonance imaging , endothelium , evans blue , vascular permeability , vasodilation , endocrinology , pathology , chemistry , radiology , in vitro , biochemistry , disease
Endothelial dysfunction promotes atherosclerosis and precedes acute cardiovascular events. We investigated whether in vivo magnetic resonance imaging with the use of an albumin-binding contrast agent, gadofosveset, could detect endothelial damage associated with atherosclerosis in apolipoprotein E-deficient (ApoE(-/-)) mice. Furthermore, we tested whether magnetic resonance imaging could noninvasively assess endothelial function by measuring the endothelial-dependent vasodilation in response to acetylcholine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom